Similar articles

• Decreased number of CD73 (ecto-5'-nucleotidase) molecules on lymphocytes from patients with primary immunoglobulin deficiencies. Correlation between number of CD73 molecules and T-lymphocyte function in vitro.

  Christensen LD, Andersen V, Ryder L. Christensen LD, et al. Scand J Immunol. 1996 Jul;44(1):62-70. doi: 10.1046/j.1365-3083.1996.d01-281.x. Scand J Immunol. 1996. PMID: 8693293
• Ecto-5'-nucleotidase activity is not required for T cell activation through CD73.

  Gutensohn W, Resta R, Misumi Y, Ikehara Y, Thompson LF. Gutensohn W, et al. Cell Immunol. 1995 Apr 1;161(2):213-7. doi: 10.1006/cimm.1995.1029. Cell Immunol. 1995. PMID: 7697732
• Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5'-nucleotidase (CD73).

  Thomson LF, Ruedi JM, Glass A, Moldenhauer G, Moller P, Low MG, Klemens MR, Massaia M, Lucas AH. Thomson LF, et al. Tissue Antigens. 1990 Jan;35(1):9-19. doi: 10.1111/j.1399-0039.1990.tb01750.x. Tissue Antigens. 1990. PMID: 2137649
• CD73 (ecto-5'-nucleotidase) on blood mononuclear cells. Regulation of ecto-5'-nucleotidase activity and antigenic heterogeneity of CD73 on blood mononuclear cells from healthy donors and from patients with immunodeficiency.

  Christensen LD. Christensen LD. APMIS Suppl. 1997;73:1-28. APMIS Suppl. 1997. PMID: 9393563 Review. No abstract available.
• CD73: a novel target for cancer immunotherapy.

  Zhang B. Zhang B. Cancer Res. 2010 Aug 15;70(16):6407-11. doi: 10.1158/0008-5472.CAN-10-1544. Epub 2010 Aug 3. Cancer Res. 2010. PMID: 20682793 Free PMC article. Review.